Product Code: TMRGL35705
Scope of Report
The report provides revenue of the global smart insulin pens market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global smart insulin pens market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the smart insulin pens market.
The report delves into the competitive landscape of the global smart insulin pens market. Key players operating in the global smart insulin pens market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global smart insulin pens market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Smart Insulin Pens Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Smart Insulin Pens Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Type-I Diabetes Prevalence by region/globally
- 5.3. Regulatory Scenario by Region/globally
- 5.4. Key Industry Events (mergers, acquisitions, partnerships, etc.)
- 5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Smart Insulin Pens Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Smart Insulin Pens
- 6.3.2. Adaptors for Conventional Pens
- 6.4. Market Attractiveness Analysis, by Product
7. Global Smart Insulin Pens Market Analysis and Forecast, by Connectivity Type
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Connectivity Type, 2017-2031
- 7.3.1. Bluetooth
- 7.3.2. USB
- 7.4. Market Attractiveness Analysis, by Connectivity Type
8. Global Smart Insulin Pens Market Analysis and Forecast, by Application
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Application, 2017-2031
- 8.3.1. Type 1 Diabetes
- 8.3.2. Type 2 Diabetes
- 8.4. Market Attractiveness Analysis, by Application
9. Global Smart Insulin Pens Market Analysis and Forecast, by Distribution Channel
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 9.3.1. Hospital Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. Diabetes Clinics/Centers
- 9.3.4. E-commerce
- 9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Smart Insulin Pens Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness Analysis, by Region
11. North America Smart Insulin Pens Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Smart Insulin Pens
- 11.2.2. Adaptors for Conventional Pens
- 11.3. Market Value Forecast, by Connectivity Type, 2017-2031
- 11.3.1. Bluetooth
- 11.3.2. USB
- 11.4. Market Value Forecast, by Application, 2017-2031
- 11.4.1. Type 1 Diabetes
- 11.4.2. Type 2 Diabetes
- 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.5.1. Hospital Pharmacies
- 11.5.2. Retail Pharmacies
- 11.5.3. Diabetes Clinics/Centers
- 11.5.4. E-commerce
- 11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Connectivity Type
- 11.7.3. By Application
- 11.7.4. By Distribution Channel
- 11.7.5. By Country
12. Europe Smart Insulin Pens Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Smart Insulin Pens
- 12.2.2. Adaptors for Conventional Pens
- 12.3. Market Value Forecast, by Connectivity Type, 2017-2031
- 12.3.1. Bluetooth
- 12.3.2. USB
- 12.4. Market Value Forecast, by Application, 2017-2031
- 12.4.1. Type 1 Diabetes
- 12.4.2. Type 2 Diabetes
- 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.5.1. Hospital Pharmacies
- 12.5.2. Retail Pharmacies
- 12.5.3. Diabetes Clinics/Centers
- 12.5.4. E-commerce
- 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Product
- 12.7.2. By Connectivity Type
- 12.7.3. By Application
- 12.7.4. By Distribution Channel
- 12.7.5. By Country/Sub-region
13. Asia Pacific Smart Insulin Pens Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Smart Insulin Pens
- 13.2.2. Adaptors for Conventional Pens
- 13.3. Market Value Forecast, by Connectivity Type, 2017-2031
- 13.3.1. Bluetooth
- 13.3.2. USB
- 13.4. Market Value Forecast, by Application, 2017-2031
- 13.4.1. Type 1 Diabetes
- 13.4.2. Type 2 Diabetes
- 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.5.1. Hospital Pharmacies
- 13.5.2. Retail Pharmacies
- 13.5.3. Diabetes Clinics/Centers
- 13.5.4. E-commerce
- 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Product
- 13.7.2. By Connectivity Type
- 13.7.3. By Application
- 13.7.4. By Distribution Channel
- 13.7.5. By Country/Sub-region
14. Latin America Smart Insulin Pens Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Smart Insulin Pens
- 14.2.2. Adaptors for Conventional Pens
- 14.3. Market Value Forecast, by Connectivity Type, 2017-2031
- 14.3.1. Bluetooth
- 14.3.2. USB
- 14.4. Market Value Forecast, by Application, 2017-2031
- 14.4.1. Type 1 Diabetes
- 14.4.2. Type 2 Diabetes
- 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.5.1. Hospital Pharmacies
- 14.5.2. Retail Pharmacies
- 14.5.3. Diabetes Clinics/Centers
- 14.5.4. E-commerce
- 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Product
- 14.7.2. By Connectivity Type
- 14.7.3. By Application
- 14.7.4. By Distribution Channel
- 14.7.5. By Country/Sub-region
15. Middle East & Africa Smart Insulin Pens Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Smart Insulin Pens
- 15.2.2. Adaptors for Conventional Pens
- 15.3. Market Value Forecast, by Connectivity Type, 2017-2031
- 15.3.1. Bluetooth
- 15.3.2. USB
- 15.4. Market Value Forecast, by Application, 2017-2031
- 15.4.1. Type 1 Diabetes
- 15.4.2. Type 2 Diabetes
- 15.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 15.5.1. Hospital Pharmacies
- 15.5.2. Retail Pharmacies
- 15.5.3. Diabetes Clinics/Centers
- 15.5.4. E-commerce
- 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Product
- 15.7.2. By Connectivity Type
- 15.7.3. By Application
- 15.7.4. By Distribution Channel
- 15.7.5. By Country/Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 16.2. Market Share Analysis, by Company, 2021
- 16.3. Company Profiles
- 16.3.1. Novo Nordisk A/S
- 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.1.2. Product Portfolio
- 16.3.1.3. Financial Overview
- 16.3.1.4. SWOT Analysis
- 16.3.1.5. Strategic Overview
- 16.3.2. Sanofi (Sanofi-Aventis US LLC)
- 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.2.2. Product Portfolio
- 16.3.2.3. Financial Overview
- 16.3.2.4. SWOT Analysis
- 16.3.2.5. Strategic Overview
- 16.3.3. Eli Lilly and Company
- 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.3.2. Product Portfolio
- 16.3.3.3. Financial Overview
- 16.3.3.4. SWOT Analysis
- 16.3.3.5. Strategic Overview
- 16.3.4. Medtronic plc
- 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.4.2. Product Portfolio
- 16.3.4.3. Financial Overview
- 16.3.4.4. SWOT Analysis
- 16.3.4.5. Strategic Overview
- 16.3.5. Emperra GmbH
- 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.5.2. Product Portfolio
- 16.3.5.3. Financial Overview
- 16.3.5.4. SWOT Analysis
- 16.3.5.5. Strategic Overview
- 16.3.6. Bigfoot Biomedical
- 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.6.2. Product Portfolio
- 16.3.6.3. Financial Overview
- 16.3.6.4. SWOT Analysis
- 16.3.6.5. Strategic Overview
- 16.3.7. Jiangsu Deflu Medical Device Co. Ltd.
- 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.7.2. Product Portfolio
- 16.3.7.3. Financial Overview
- 16.3.7.4. SWOT Analysis
- 16.3.7.5. Strategic Overview
- 16.3.8. Diamesco Co. Ltd.
- 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.8.2. Product Portfolio
- 16.3.8.3. Financial Overview
- 16.3.8.4. SWOT Analysis
- 16.3.8.5. Strategic Overview
- 16.3.9. Ypsomed Holding AG
- 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.9.2. Product Portfolio
- 16.3.9.3. Financial Overview
- 16.3.9.4. SWOT Analysis
- 16.3.9.5. Strategic Overview